Results With HUMIRA

With HUMIRA, remission is possible for ulcerative colitis
Approximately 2x more likely to achieve ulcerative colitis remission on HUMIRA at 8 weeks

In one clinical study, 18.5% of patients with moderate to severe ulcerative colitis (UC) achieved remission as early as 8 weeks versus 9.2% on placebo. In a second study, 16.5% of patients achieved remission on HUMIRA at 8 weeks versus 9.3% on placebo. Individual results may vary.

One clinical trial showed that 17.3% of HUMIRA for UC patients achieved and maintained remission at 52 weeks

A controlled study of 494 patients included those who were new to a biologic as well as those who had taken a biologic treatment in the past. At week 52, 17.3% were in remission with HUMIRA compared to 8.5% taking placebo.  Individual results may vary.

A HUMIRA Testimonial from Dr. Remo Panaccione: “linical remission is a key goal. For my moderate to severe UC patients I look for treatment that is proven to achieve that goal rapidly.”

Common side effects with HUMIRA include:

  • injection site reactions: redness, rash, swelling, itching, or bruising. These symptoms usually will go away within a few days. Call your doctor right away if you have pain, redness or swelling around the injection site that does not go away within a few days or gets worse
  • upper respiratory infections (including sinus infections)
  • headaches
  • rash

Are you currently using HUMIRA to treat your moderate to severe UC?

Visit HUMIRA Complete for access to potential savings, personalized support, and resources to help you stay on track with your prescribed treatment plan.

Learn About HUMIRA Complete 

Interested in learning about a once-daily pill for people with moderate to severe UC who are still experiencing symptoms with a TNF blocker, like HUMIRA?

Learn more

Having my symptoms under control meant I didn’t have to worry about where the nearest restroom was whenever I went out.

- Maria, a real UC patient using HUMIRA

Wondering what it’s like to be in remission? Hear from HUMIRA patients who know.

HUMIRA Complete logo

HUMIRA Complete provides access to a variety of resources

Illustration of a dollar sign

Eligible patients may pay less than $5/month* 

Eligible, commercially-insured patients may pay as little as $5 per month, every month with the HUMIRA Complete Savings Card. Get started

Illustration of a question mark

Have insurance coverage questions?

To help you get off to a good start with your HUMIRA prescription, Insurance Specialists are available to help you understand your HUMIRA coverage.

Illustration of a phone call

Has COVID-19 made paying for your medicine a challenge?

AbbVie may be able to help. Call 1.800.4HUMIRA

Eligibility: Available to patients with commercial insurance coverage for HUMIRA® (adalimumab) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit or call 1.800.4HUMIRA for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit

Recommended for you:

Illustration of arrows pointing at circle


Illustration of a video player

HUMIRA Patient Stories